Actively Recruiting
Study of Early Stages and Progression of CADASIL Vascular Dementia with Genetic Testing and Brain Assessments
Led by University of Wisconsin, Madison · Updated on 2026-01-15
660
Participants Needed
12
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy CADASIL, a common inherited vascular dementia that leads to vascular cognitive impairment and dementia VCID. This observational study aims to understand the risk factors and progression of CADASIL by examining biological, imaging, and clinical changes from early to symptomatic stages. The study will enroll 575 participants with a family history of CADASIL who have undergone genetic testing for a NOTCH3 variant. Participants will be grouped based on their genetic status and symptoms healthy family members without the NOTCH3 mutation, pre-symptomatic members with the mutation, symptomatic members without functional decline, and symptomatic members with early dementia signs. The study involves no drug treatment but includes clinical interviews, neurological exams, neurocognitive and behavioral assessments, MRI scans, and blood draws. There will be three in-person visits at baseline, 18 months, and 36 months, with additional remote contacts as needed. During the study, participants will complete evaluations to measure cognitive function, brain volume, brain connectivity, and biomarkers like Neurofilament Light. The researchers will track changes over 36 months and assess disability and disease severity scores. Participants will be monitored through clinical exams, imaging, and questionnaires, with a total commitment of up to five years. The study aims to gather detailed information on CADASIL progression and factors influencing outcomes.
CONDITIONS
Brief Title
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
Research Team
C
Cadasil Consortium
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here